Overview

Effect of Darbepoetin in Contrast-induced Nephropathy

Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the drug that produce red blood cells is effective in the prevention of kidney dysfunction after coronary angiography in patients with chronic kidney disease.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Seoul National University Bundang Hospital
Collaborator:
SMG-SNU Boramae Medical Center
Treatments:
Darbepoetin alfa